Clinical trials sponsored by Canadian Cancer Trials Group
9
Recruiting trials
14
Conditions studied
Phase breakdown
Phase 1 1Phase 2 2Phase 3 6
Conditions studied
Recruiting trials led by Canadian Cancer Trials Group
- Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Duration of Anti-PD-1 Therapy in Metastatic Melanoma
- GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
- LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma
- Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
- Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes
- Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Common questions
How many trials is Canadian Cancer Trials Group recruiting for?
Canadian Cancer Trials Group is the lead sponsor of 9 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.